Santhera Pharmaceuticals Holding AG (OTCMKTS:SPHDF) Short Interest Update

Santhera Pharmaceuticals Holding AG (OTCMKTS:SPHDF) was the recipient of a significant increase in short interest in March. As of March 15th, there was short interest totalling 7,300 shares, an increase of 102.8% from the February 28th total of 3,600 shares. Based on an average trading volume of 100 shares, the days-to-cover ratio is presently 73.0 days.

Santhera Pharmaceuticals Price Performance

SPHDF stock remained flat at $17.01 during trading on Friday. The business’s 50 day simple moving average is $11.37 and its 200 day simple moving average is $11.06. Santhera Pharmaceuticals has a 12 month low of $16.00 and a 12 month high of $17.01.

Santhera Pharmaceuticals Company Profile

Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the European Union and internationally. The company's lead pipeline candidate includes Vamorolone, which is being developed for the treatments of Duchenne muscular dystrophy (DMD).